Wordt geladen...
Intestinal SGLT1 as a therapeutic target in COVID‐19‐related diabetes: A “two‐edged sword” hypothesis
Emerging data are linking coronavirus disease 2019 (COVID‐19) with an increased risk of developing new‐onset diabetes. The gut has been so far out of the frame of the discussion on the pathophysiology of COVID‐19‐induced diabetes, with the pancreas, liver, and adipose tissue being under the spotligh...
Bewaard in:
| Gepubliceerd in: | Br J Clin Pharmacol |
|---|---|
| Hoofdauteurs: | , , , |
| Formaat: | Artigo |
| Taal: | Inglês |
| Gepubliceerd in: |
John Wiley and Sons Inc.
2021
|
| Onderwerpen: | |
| Online toegang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8251113/ https://ncbi.nlm.nih.gov/pubmed/33684969 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/bcp.14800 |
| Tags: |
Voeg label toe
Geen labels, Wees de eerste die dit record labelt!
|